Early recurrence of atrial arrhythmia and health care utilization during the 8-week blanking period after thermal energy catheter ablation of atrial fibrillation
- PMID: 41371532
- DOI: 10.1016/j.hrthm.2025.12.010
Early recurrence of atrial arrhythmia and health care utilization during the 8-week blanking period after thermal energy catheter ablation of atrial fibrillation
Keywords: Atrial fibrillation; Blanking period; Catheter ablation; Colchicine; Health care utilization; Recurrence.
Conflict of interest statement
Disclosures Dr Benz has received speaking fees from Bristol Myers Squibb and AstraZeneca and participated in an educational program with Boston Scientific. Dr Amit has served on the advisory board of Johnson & Johnson. Dr McIntyre has received consulting fees from AtriCure and speaking fees from iRhythm. Dr Conen has received consulting fees from Roche and Trimedics and speaking fees from Servier and Bristol Myers Squibb/Pfizer. Dr Roberts has received speaking fees from Bristol Myers Squibb and Ionis. Dr Williams has received speaking fees from Biosense Webster. Dr Healey has received consulting fees, speaking fees, and research support from Boston Scientific and speaking fees and research support from Medtronic. The rest of the authors report no conflicts of interest.
LinkOut - more resources
Full Text Sources
